Answers are grounded in this paper and cite their sources.
Background/Objectives: Xanthine oxidase (XO) is a therapeutic target for hyperuricemia. Although hydnocarpin inhibits XO, its comparative potency and kinetic characteristics remain insufficiently characterized. This study investigated XO-inhibitory constituents of Hydnocarpus anthelmintica through affinity-guided dereplication. Methods: Extracts and fractions were screened for XO inhibition. Affinity ultrafiltration and chromatographic profiling guided compound identification. Three flavonoids were identified using authentic standards, whereas hydnocarpin was isolated and characterized. Inhibitory activities, enzyme kinetics, and molecular docking were evaluated, with allopurinol serving as a positive control in the inhibition assay. Results: The EtOAc fraction exhibited potent XO inhibition (IC50 = 2.7 ± 0.3 µg/mL). Among the four compounds evaluated, hydnocarpin (4) showed the strongest inhibitory activity (IC50 = 0.10 ± 0.01 µM), followed by luteolin (1, 0.41 ± 0.04 µM), chrysoeriol (3, 0.62 ± 0.03 µM), and apigenin (2, 0.76 ± 0.07 µM). Allopurinol, used as the positive control, exhibited an IC50 of 4.2 ± 0.4 µM. Kinetic analysis indicated mixed-type inhibition, with KI and KIS values of 0.079 and 0.158 µM, respectively. Molecular docking suggested differences in predicted interactions between two hypothetical stereochemical models, although the absolute configuration of the isolated compound was not determined. Conclusions: Affinity-guided dereplication identified potent XO-inhibitory constituents of H. anthelmintica, highlighting hydnocarpin as the strongest inhibitor among those tested and supporting further mechanistic investigation.
No takes yet. Share an insight, caveat, or question.
Yuk et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: